iBE Connect

iBE Connect from UE LifeSciences

90% of the developing world and millions of women don't have access to breast cancer early detection. The incidence of breast cancer is expected to continue growing (after doubling in just two decades) and with that the mortality rate mainly due to late stage detection.

With innovative technologies and a passionate team, our mission is to make the hope of early detection a reality.